This segment focuses on the research, development, manufacturing, and marketing of transdermal drug delivery systems. The primary product is transdermal nitroglycerin patches used for the relief of angina pectoris symptoms. Research and development activities include improving patch technology for enhanced drug absorption and patient compliance. The company utilizes technologies such as polymer matrix systems and adhesive technologies to ensure effective drug delivery through the skin. The therapeutic area is cardiology, specifically addressing the needs of patients with angina. The impact is improved quality of life and reduced chest pain for patients. Health-Chem Corp. has a market position in the transdermal nitroglycerin market, competing with other pharmaceutical companies. Future opportunities include expanding the product line and exploring new applications for transdermal delivery. Regulatory aspects involve FDA approval and compliance with manufacturing standards. The company markets its products directly to wholesalers, distributors, and retail pharmacy chains.

This segment provides research and development services to third parties on a contract basis. The company leverages its expertise in transdermal drug delivery systems and related technologies to conduct research projects for other pharmaceutical and biotechnology companies. Research activities include formulation development, pre-clinical testing, and clinical trial support. The technologies and methodologies used include analytical chemistry, formulation science, and pharmacokinetic studies. The therapeutic areas covered can vary depending on the client's needs, but often include cardiovascular, pain management, and other areas where transdermal delivery is applicable. The patient impact is indirect, as the research contributes to the development of new drugs and therapies. Health-Chem Corp. positions itself as a reliable partner for companies seeking expertise in transdermal drug delivery. Future opportunities include expanding the client base and offering a wider range of research services. Regulatory aspects depend on the specific projects and the client's requirements. Partnerships and collaborations are essential for this segment, as the company works closely with other organizations to advance drug development.